Ribavirin does not potentiate favipiravir antiviral activity against Ebola virus in non-human primates.

Antiviral Research
Vincent MadelainJérémie Guedj

Abstract

In spite of recurrent and dramatic outbreaks, there are no therapeutics approved against Ebola virus disease. Favipiravir, a RNA polymerase inhibitor active against several RNA viruses, recently demonstrated significant but not complete protection in a non-human primate model of Ebola virus disease. In this study, we assessed the benefit of the combination of favipiravir and ribavirin, another broad spectrum antiviral agent, in the same model. 15 female cynomolgus macaques were challenged intramuscularly with 1,000 FFU of Ebola virus Gabon 2001 strain and followed for 21 days. All animals received favipiravir 180 mg/kg twice a day (BID), either as monotherapy (n = 5) or in combination with ribavirin (n = 10). Ribavirin was given either at the dose 10 mg/kg BID (n = 5) or 5 mg/kg BID (n = 5). Favipiravir and ribavirin were initiated two and one days before viral challenge respectively and treatment were continued for 14 days. Treatment effects on viral and hematological markers were assessed using a mathematical model. Survival rate of 0% and 20% were obtained in macaques receiving favipiravir plus ribavirin 10 and 5 mg/kg BID, respectively, compared to 40% in the favipiravir monotherapy group (P = 0.061 when comparing monothera...Continue Reading

References

Mar 1, 1984·The Journal of Infectious Diseases·P B JahrlingE L Stephen
Jun 30, 1984·Toxicology and Applied Pharmacology·P G CanonicoE L Stephen
Dec 19, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lena E FribergMats O Karlsson
Dec 25, 2002·Antimicrobial Agents and Chemotherapy·Sylvie LarratClaude Souvignet
Mar 26, 2003·Antimicrobial Agents and Chemotherapy·Chin-Chung LinJohnson Y N Lau
Jan 15, 2005·Virus Research·William B Parker
Feb 25, 2005·Antimicrobial Agents and Chemotherapy·Yousuke FurutaKimiyasu Shiraki
Dec 16, 2006·Current Medicinal Chemistry·Stefan RussmannGiuseppe Palasciano
Jun 19, 2007·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Arianna LoregianGiorgio Palù
Nov 10, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Daniel G BauschJuan J L Lertora
Aug 1, 2012·Journal of Pharmacokinetics and Pharmacodynamics·Rocío Lledó-GarcíaMats O Karlsson
Jan 1, 2014·Scientific Data·Adrian MylneSimon I Hay
May 26, 2015·Expert Opinion on Drug Discovery·Amy C Shurtleff, Sina Bavari
Nov 5, 2015·The Journal of Infectious Diseases·Lisa OestereichStephan Günther
Dec 18, 2015·Journal of Virology·Kendra J AlfsonAnthony Griffiths
Nov 1, 2016·Antimicrobial Agents and Chemotherapy·Vincent MadelainHervé Raoul
Oct 25, 2016·Antiviral Research·Stephen R WelchCésar G Albariño
Oct 26, 2016·Frontiers in Public Health·Kim J Brolin RibackeJohan von Schreeb
Feb 24, 2017·PLoS Neglected Tropical Diseases·Thi Huyen Tram NguyenUNKNOWN JIKI study group
Aug 5, 2017·Proceedings of the Japan Academy. Series B, Physical and Biological Sciences·Yousuke FurutaTakaaki Nakamura
Oct 12, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Vanessa N RaabeUNKNOWN Emory Serious Communicable Diseases Unit

❮ Previous
Next ❯

Citations

Sep 22, 2020·European Journal of Pharmacology·Kiavash HushmandiSeyed Mohammad Nabavi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

Disaster Medicine and Public Health Preparedness
Takashi NagataMasami Ishii
The Lancet Infectious Diseases
France MentréDenis Malvy
Antiviral Research
Vincent MadelainJérémie Guedj
© 2021 Meta ULC. All rights reserved